No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Structural fingerprints and their evolution during oligomeric vs. oligomer-free amyloid fibril growth
2. P. Li, S. Banjade, H.-C. Cheng, S. Kim, B. Chen, L. Guo, M. Llaguno, J. V. Hollingsworth, D. S. King, S. F. Banani, P. S. Russo, Q.-X. Jiang, B. T. Nixon, and M. K. Rosen, Nature (London) 483(7389), 336 (2012).
7. D. M. Fowler, A. V. Koulov, C. Alory-Jost, M. S. Marks, W. E. Balch, and J. W. Kelly, PLoS Biol. 4(1), e6–1 (2005);
7.S. K. Maji, M. H. Perrin, M. R. Sawaya, S. Jessberger, K. Vadodaria, R. A. Rissman, P. S. Singru, K. P. R. Nilsson, R. Simon, D. Schubert, D. Eisenberg, J. Rivier, P. Sawchenko, W. Vale, and R. Riek, Science 325(5938), 328 (2009).
11. V. N. Uversky, A. Fernandez, and A. L. Fink, in Protein Misfolding, Aggregation and Conformational Diseases. Part A: Protein Aggregation and Conformational Diseases, edited by N. U. Vladimir and A. L. Fink (Springer, New York, 2006);
16. M. N. N. Vieira, L. Forny-Germano, L. M. Saraiva, A. Sebollela, A. M. B. Martinez, J.-C. Houzel, F. G. De Felice, and S. T. Ferreira, J. Neurochem. 103(2), 736 (2007);
16.R. Kayed, E. Head, F. Sarsoza, T. Saing, C. Cotman, M. Necula, L. Margol, J. Wu, L. Breydo, J. Thompson, S. Rasool, T. Gurlo, P. Butler, and C. Glabe, Mol. Neurodegeneration 2(1), 18 (2007);
16.J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski, D. J. Selkoe, and K. H. Ashe, Nat. Neurosci. 8, 79 (2005);
16.D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe, Nature (London) 416(6880), 535 (2002).
20. D. R. Booth, M. Sunde, V. Bellotti, C. V. Robinson, W. L. Hutchinson, P. E. Fraser, P. N. Hawkins, C. M. Dobson, S. E. Radford, C. F. F. Blake, and M. B. Pepys, Nature (London) 385, 787 (1997);
20.M. B. Pepys, P. N. Hawkins, D. R. Booth, D. M. Vigushin, G. A. Tennent, A. K. Soutar, N. Totty, O. Nguyen, C. C. F. Blake, C. J. Terry, T. G. Feest, A. M. Zalin, and J. J. Hsuan, Nature (London) 362(6420), 553 (1993).
22. L. N. Arnaudov and R. de Vries, Biophys. J. 88(1), 515 (2005);
22.M. R. H. Krebs, D. K. Wilkins, E. W. Chung, M. C. Pitkeathly, A. K. Chamberlain, J. Zurdo, C. V. Robinson, and C. M. Dobson, J. Mol. Biol. 300(3), 541 (2000).
28. H. Z. Cummins, in Photon Correlation and Light Beating Spectroscopy, edited by H. Z. Cummins and E. R. Pike (Plenum Press, New York, 1973).
29. M. Tanaka, S. R. Collins, B. H. Toyama, and J. S. Weissman, Nature (London) 442(7102), 585 (2006);
29.T. P. J. Knowles, C. A. Waudby, G. L. Devlin, S. I. A. Cohen, A. Aguzzi, M. Vendruscolo, E. M. Terentjev, M. E. Welland, and C. M. Dobson, Science 326, 1533 (2009).
33. A. Laganowsky, C. Liu, M. R. Sawaya, J. P. Whitelegge, J. Park, M. Zhao, A. Pensalfini, A. B. Soriaga, M. Landau, P. K. Teng, D. Cascio, C. Glabe, and D. Eisenberg, Science 335(6073), 1228 (2012).
Article metrics loading...
Deposits of fibrils formed by disease-specific proteins are the molecular hallmark of such diverse human disorders as Alzheimer's disease, type II diabetes, or rheumatoid arthritis. Amyloid fibril formation by structurally and functionally unrelated proteins exhibits many generic characteristics, most prominently the cross β-sheet structure of their mature fibrils. At the same time, amyloid formation tends to proceed along one of two separate assembly pathways yielding either stiff monomeric filaments or globular oligomers and curvilinear protofibrils. Given the focus on oligomers as major toxic species, the very existence of an oligomer-free assembly pathway is significant. Little is known, though, about the structure of the various intermediates emerging along different pathways and whether the pathways converge towards a common or distinct fibril structures. Using infrared spectroscopy we probed the structural evolution of intermediates and late-stage fibrils formed during in vitro lysozyme amyloid assembly along an oligomeric and oligomer-free pathway. Infrared spectroscopy confirmed that both pathways produced amyloid-specific β-sheet peaks, but at pathway-specific wavenumbers. We further found that the amyloid-specific dye thioflavin T responded to all intermediates along either pathway. The relative amplitudes of thioflavin T fluorescence responses displayed pathway-specific differences and could be utilized for monitoring the structural evolution of intermediates. Pathway-specific structural features obtained from infrared spectroscopy and Thioflavin T responses were identical for fibrils grown at highly acidic or at physiological pH values and showed no discernible effects of protein hydrolysis. Our results suggest that late-stage fibrils formed along either pathway are amyloidogenic in nature, but have distinguishable structural fingerprints. These pathway-specific fingerprints emerge during the earliest aggregation events and persist throughout the entire cascade of aggregation intermediates formed along each pathway.
Full text loading...
Most read this month